Display options
Share it on

Stroke Res Treat. 2016;2016:2410921. doi: 10.1155/2016/2410921. Epub 2016 Jun 19.

Influence of Medication on Fatigue Six Months after Stroke.

Stroke research and treatment

Amélie Ponchel, Julien Labreuche, Stéphanie Bombois, Christine Delmaire, Régis Bordet, Hilde Hénon

Affiliations

  1. Degenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, France; Department of Medical Pharmacology, Univ. Lille, 59000 Lille, France; Department of Neurology, Lille University Hospital, 59000 Lille, France.
  2. Department of Statistics, EA 2694, Univ. Lille, 59000 Lille, France.
  3. Degenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, France; Department of Neurology, Lille University Hospital, 59000 Lille, France.
  4. Degenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, France; Department of Neuroradiology, Lille University Hospital, 59000 Lille, France.
  5. Degenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, France; Department of Medical Pharmacology, Univ. Lille, 59000 Lille, France.

PMID: 27413577 PMCID: PMC4930814 DOI: 10.1155/2016/2410921

Abstract

Poststroke fatigue (PSF) is frequent and affects patients' quality of life. Medication use was hypothesized as being responsible for PSF. Our objective was to evaluate potential relationships between 6-month PSF and medication use at discharge and 6 months after an ischemic stroke. This study is part of STROKDEM, an ongoing longitudinal cohort study, whose main aim is to determine predictors of poststroke dementia. Patients were included within 72 hours after an ischemic stroke and followed up with standardized evaluations. Medication use 7 days and 6 months after stroke was rated, and polypharmacy was defined as the number of categories of treatments received by a patient. PSF was evaluated using the Chalder Fatigue Scale. Medical history, vascular risk factors, depression, anxiety, and sleep disturbances were evaluated. One hundred and fifty-three patients were included: 52.9% presented PSF. PSF at 6 months was not predicted by medication use at discharge nor associated with medication use at month 6. We found severity of PSF to be increased in patients with polypharmacy. Our results suggest that PSF is not a side effect of drugs use, which more reflects presence of disturbances frequently observed after stroke such as depression, anxiety, or sleep disturbances. Clinical study is registered on clinicaltrials.gov (NCT01330160).

References

  1. PLoS One. 2014 Oct 10;9(10):e110037 - PubMed
  2. J Neurol Sci. 2012 Jan 15;312(1-2):138-41 - PubMed
  3. Int J Stroke. 2015 Oct;10(7):1130-40 - PubMed
  4. Stroke Res Treat. 2015;2015:347920 - PubMed
  5. PM R. 2010 May;2(5):451-5 - PubMed
  6. Scott Med J. 1957 May;2(5):200-15 - PubMed
  7. Occup Med (Lond). 2015 Jan;65(1):86 - PubMed
  8. Cerebrovasc Dis. 2007;23(2-3):103-8 - PubMed
  9. Disabil Rehabil. 2011;33(4):334-42 - PubMed
  10. Arch Intern Med. 2012 Aug 13;172(15):1180-2 - PubMed
  11. Arch Phys Med Rehabil. 2003 Nov;84(11):1714-20 - PubMed
  12. Acta Neurochir (Wien). 2013 Jun;155(6):1107-14 - PubMed
  13. Eur Neurol. 2001;45(1):3-5 - PubMed
  14. Pharmacotherapy. 2010 Jun;30(6):541-53 - PubMed
  15. PLoS One. 2011 Mar 18;6(3):e16988 - PubMed
  16. Int J Stroke. 2015 Jun;10(4):506-12 - PubMed
  17. J Psychosom Res. 1993;37(2):147-53 - PubMed
  18. J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1120-6 - PubMed
  19. J Stroke. 2014 Sep;16(3):195-201 - PubMed
  20. Stroke. 2002 May;33(5):1327-33 - PubMed
  21. Cerebrovasc Dis. 2005;19(2):84-90 - PubMed
  22. J Health Psychol. 2016 Dec;21(12 ):2863-2871 - PubMed
  23. Int J Environ Res Public Health. 2016 Jan 21;13(1):null - PubMed
  24. Br J Med Psychol. 1959;32(1):50-5 - PubMed
  25. Phys Med Rehabil Clin N Am. 2009 May;20(2):347-61 - PubMed
  26. Eur Neurol. 2012;67(6):377-84 - PubMed
  27. Psychol Med. 1989 Nov;19(4):1015-22 - PubMed
  28. Psychol Med. 2013 Oct;43(10):2227-35 - PubMed
  29. Pain Med. 2014 Jul;15(7):1163-70 - PubMed
  30. Md State Med J. 1965 Feb;14:61-5 - PubMed
  31. Arch Gerontol Geriatr. 2011 Sep-Oct;53(2):e164-7 - PubMed
  32. J Psychosom Res. 2004 Feb;56(2):157-70 - PubMed
  33. PLoS One. 2015 Nov 24;10(11):e0142726 - PubMed
  34. Cerebrovasc Dis. 2012;33(5):461-5 - PubMed
  35. Clin Rehabil. 2016 May;30(5):454-62 - PubMed
  36. BMJ. 1990 Nov 24;301(6762):1199-202 - PubMed
  37. BMC Gastroenterol. 2013 Feb 12;13:28 - PubMed
  38. Cerebrovasc Dis. 2007;23 (1):40-5 - PubMed
  39. Occup Ther Int. 2010 Jun;17 (2):81-91 - PubMed
  40. J Affect Disord. 1988 Jan-Feb;14(1):61-8 - PubMed
  41. QJM. 2009 Feb;102(2):109-15 - PubMed
  42. Neurology. 2013 Oct 29;81(18):1581-7 - PubMed
  43. Mult Scler. 2016 Apr;22(5):677-84 - PubMed
  44. Disabil Rehabil. 2012;34(8):633-7 - PubMed
  45. Stroke. 1986 Mar-Apr;17(2):241-5 - PubMed
  46. Arch Phys Med Rehabil. 1999 Feb;80(2):173-8 - PubMed
  47. J Psychosom Res. 1998 Jul;45(1):53-65 - PubMed
  48. Stroke. 2009 Mar;40(3):757-61 - PubMed
  49. Vasc Health Risk Manag. 2012;8:407-13 - PubMed
  50. Cochrane Database Syst Rev. 2015 Jul 02;(7):CD007030 - PubMed
  51. Stroke. 1989 Jul;20(7):864-70 - PubMed
  52. Stroke. 2015 Mar;46(3):893-8 - PubMed
  53. Acta Neurol Scand. 2012 Apr;125(4):248-53 - PubMed
  54. BMJ Open. 2013 Mar 01;3(3):null - PubMed
  55. Arch Phys Med Rehabil. 2010 Oct;91(10 ):1511-5 - PubMed

Publication Types